Physician profile
James B Kesl
NPI 1457615866
$6,705.67
in general payments reported to CMS, 2019-2025
14 companies · $461 in 2025
The $461 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,255 · 2020: $1,292 · 2021: $1,375 · 2022: $167 · 2023: $573 · 2024: $583 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,617.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,039.67 | 2019-2025 | Gamma, T2 Alpha, Variax |
| Titan Surgical Group, LLC | $987.49 | 2020 | |
| Zimmer Biomet Holdings, INC. | $599.41 | 2019-2025 | M/V Instruments, Copios Bone Void Filler Paste, A.L.P.S. |
| Depuy Synthes Sales INC. | $564.01 | 2019-2024 | Attune, Tfn-Advance, Na |
| Si-Bone, INC. | $120.87 | 2024 | |
| Wright Medical Technology, INC. | $84.35 | 2019 | |
| Skeletal Dynamics INC | $75.00 | 2025 | Align, Implate, Geminus |
| Boston Scientific Corporation | $70.54 | 2019 | |
| Bioventus LLC | $55.10 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Biocomposites INC | $45.18 | 2025 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $18.60 | 2025 | Zilretta, Iovera |
| Acera Surgical, INC. | $16.25 | 2024 | Restrata Wound Matrix |
| Access Pro Medical, LLC | $14.87 | 2025 | Matriderm |
| Baudax Bio INC. | $14.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kesl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.